The well‐known mechanism for the effect of TNF‐α blockers on IBD is the induced differentiation of macrophages to the M2 phenotype and the secretion of the anti‐inflammatory cytokine IL‐10, which depends on FcR signaling.197, 198. This evidence concerns the gene TNF and inflammatory bowel disease.